The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
NeoGenomics Inc. COM NEW 64049M209 165,763 3,078,815 SH   SOLE   3,078,815 0 0
Horizon Therapeutics Public Limited Company SHS G46188101 31,965 436,975 SH   SOLE   436,975 0 0
Vericel Corporation COM 92346J108 35,535 1,150,735 SH   SOLE   1,150,735 0 0
Five9, Inc. COM 338307101 11,602 66,525 SH   SOLE   66,525 0 0
Intersect ENT Inc. COM 46071F103 229 10,000 SH   SOLE   10,000 0 0
ISHARES TR CORE 1 5 YR USD 46432F859 106 2,050 SH   SOLE   2,050 0 0
ISHARES TR CORE S&P500 ETF 464287200 110 292 SH   SOLE   292 0 0
ISHARES TR CORE MSCI EAFE 46432F842 81 1,178 SH   SOLE   1,178 0 0
ISHARES TR CORE INTL AGGR 46435G672 44 783 SH   SOLE   783 0 0
ISHARES TR CR 5 10 YR ETF 46435G417 40 764 SH   SOLE   764 0 0
ISHARES TR CORE S&P MCP ETF 464287507 34 147 SH   SOLE   147 0 0
ISHARES TR CORE MSCI EMKT 46434G103 20 316 SH   SOLE   316 0 0
ISHARES TR CORE S&P SCP ETF 464287804 19 207 SH   SOLE   207 0 0